Urolog. pro Praxi, 2008; 9(2): 89-90

Multifokální konvenční světlobuněčný karcinom v transplantované ledvině

MUDr. Lukáš Holub1, MUDr. Jaroslav Pacovský2, MUDr. Pavel Navrátil CSc1, et al
1 Urologická klinika FN a LF UK Hradec Králové
2 Urologické klinika FN a LF UK Hradec Králové, Regionální transplantační centrum Hradec Králové

Autoři prezentují incidentální nález multifokálního konvenčního světlobuněčného tumoru v transplantované ledvině u pacienta 6 let po úspěšné transplantaci. Vlastní graftektomie byla provedena pro chronickou rejekci a ztrátu funkce graftu.

Keywords: karcinom ledviny, graftektomie, imunosuprese

Published: May 21, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Holub L, Pacovský J, Navrátil P, al E. Multifokální konvenční světlobuněčný karcinom v transplantované ledvině. Urol. praxi. 2008;9(2):89-90.
Download citation

References

  1. Bleumer I, Oosterwijk E, De Mulder P, Mulders PF. Immunotherapy for renal cell carcinoma. European Urology 2003; 44(1): 65-75. Go to original source... Go to PubMed...
  2. Buell JF, Gross TG, Beebe TM, et al. Cancer after transplantation. Cancer and the kidney. Eds. Cohen E. New York: Oxford University press, 2004.
  3. Feng S, Buell JF, Cherikh WS, et al. Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation. Transplantation 2002; 74(12): 1657-1663. Go to original source... Go to PubMed...
  4. Green M, Weber S. Posttransplantation lymphoproliferative disorders. Pediatr Cicin North Am. 2003, 50: 1471-1491. Go to original source... Go to PubMed...
  5. Hora M, Hes O, Reischig T. Mnohočetné renální karcinomy při terminálním selhání ledvin. Urológia 2004; 4: 7-11.
  6. Navrátil P. Praktická urologie u nemocných v dialyzační léčbě, před a po transplantaci ledviny. Nakladatelsví Olga Čermáková, 2005: 171 s.
  7. Potter SR, Woodle ES, First MR, et al. De novo renal cell cancer after solid transplantation. Transplantation 2002; 74(Suppl 3): 587.
  8. Sheil AG. Cancer in dialysis and transpalnt patients. In: Morris PJ, editor, Kidney Transplantation. Principles and Practice. Philadelphia: Saunders, 2001: 558-570.
  9. Tannir N, Jonash E, Pagliaro LC, Mathew P, Siefker-Radtke A, Rhines L, Lin P, Tibbs R, Do KA, Lin SH, Tu SM. Pilot trial of bonetargeted therapy with zoledronate, thalidomide, and interferon gamma for metastatitic renal cell carcinoma. Cancer 2006; 107(3): 497-505. Go to original source... Go to PubMed...
  10. Tofe J, Buell JF, First MR, Hanaway MJ, Beebe T. M., Woodle ES. The role of immunosuppession in lyphoma. Recent Results Cancer Res. 2002; 159: 55-66. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.